Cercar

01/10/2022 Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients
Gil-Gomez, A, Rojas, A, Garcia-Lozano, MR, Munoz-Hernandez, R, Gallego-Duran, R, Maya-Miles, D, Montero-Vallejo, R, Gato, S, Gallego, J, Frances, R, Soriano, G, Ampuero, J, Romero-Gomez, M. Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(19)DOI:10.3390/ijms231911840. PMID:36233142. IF:5.600(Q1/3D).
01/10/2022 Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (vol 10, 2885, 2021)
Chaparro, M, Garre, A, Ortiz, AN, Palomares, MTDL, Rodriguez, C, Riestra, S, Vela, M, Benitez, JM, Salgado, EF, Rodriguez, ES, Hernandez, V, Ferreiro-Iglesias, R, Diaz, AP, Barrio, J, Huguet, JM, Sicilia, B, Martin-Arranz, MD, Calvet, X, Ginard, D, Alonso-Abreu, I, Fernandez-Salazar, L, Trastoy, PV, Rivero, M, Vera-Mendoza, I, Vega, P, Navarro, P, Sierra, M, Cabriada, JL, Aguas, M, Vicente, R, Navarro-Llavat, M, Echarri, A, Gomollon, F, del Rio, EG, Pinero, C, Casanova, MJ, Spicakova, K, de Zarate, JO, Cortes, ET, Gutierrez, A, Alonso-Galan, H, Hernandez-Martinez, A, Marrero, JM, Poyatos, RL, Calafat, M, Romero, LM, Robledo, P, Bosch, O, Jimenez, N, Comas, ME, Duque, JM, Coronel, AMF, Sampedro, MJ, Abizanda, ES, Martinez, BH, Pozzati, L, Rosaenz, HF, Suarez, BC, Serrano, PL, Lucendo, AJ, Vicente, MM, Bermejo, F, Palanca, JJR, Menacho, M, Carmona, A, Camargo, R, Alsina, ST, Maroto, N, de la Puerta, JN, Castro, E, Marin-Jimenez, I, Botella, B, Sapina, A, Cruz, N, Forcelledo, JLF, Bouhmidi, A, Castano-Milla, C, Opio, V, Nicolas, I, Kutz, M, Bechiarelli, AA, Gordillo, J, Ber, Y, Dominguez, YT, Duran, MTN, Mondejar, SR, Martinez-Cerezo, FJ, Kolle, L, Sabat, M, Ledezma, C, Iyo, E, Roncero, O, Irisarri, R, Lluis, L, Gomez, IB, Zapata, EM, Alcala, MJ, Pascual, CM, Montealegre, M, Mata, L, Monrobel, A, Camba, AH, Hernandez, L, Tejada, M, Mir, A, Galve, ML, Soler, M, Hervias, D, Gomez-Valero, JA, Acosta, MBD, Rodriguez-Artalejo, F, Garcia-Esquinas, E, Gisbert, JP. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (vol 10, 2885, 2021). Journal of Clinical Medicine. 2022; 11(19)DOI:10.3390/jcm11195816. PMID:36233844. IF:3.900(Q2/4D).
01/10/2022 Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis
Villanueva, C, Torres, F, Sarin, SK, Shah, HA, Tripathi, D, Brujats, A, Rodrigues, SG, Bhardwaj, A, Azam, Z, Hayes, PC, Jindal, A, Abid, S, Alvarado, E, Bosch, J, Carvedilol IPD MA Grp, Baveno Cooperation EASL Consortium. Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis. JOURNAL OF HEPATOLOGY. 2022; 77(4)DOI:10.1016/j.jhep.2022.05.021. PMID:35661713. IF:25.700(Q1/1D).
21/09/2022 Experimental and genetic evidence for the impact of CD5 and CD6 expression and variation in inflammatory bowel disease
Casado-Llombart, S, Velasco-de Andres, M, Catala, C, Leyton-Pereira, A, Gutierrez-Cozar, R, Suarez, B, Armiger, N, Carreras, E, Esteller, M, Ricart, E, Ordas, I, Gisbert, JP, Chaparro, M, Esteve, M, Marquez, L, Busquets, D, Iglesias, E, Garcia-Planella, E, Martin-Arranz, MD, Lohmann, J, Ayata, CK, Niess, JH, Engel, P, Panes, J, Salas, A, Domenech, E, Lozano, F. Experimental and genetic evidence for the impact of CD5 and CD6 expression and variation in inflammatory bowel disease. Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.966184. PMID:36211446. IF:7.300(Q1/3D).
01/08/2022 Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab
Chaparro, M, Baston-Rey, I, Salgado, EF, Garcia, JG, Ramos, L, Palomares, MTDL, Arguelles-Arias, F, Flores, EI, Cabello, M, Iturria, SR, Ortiz, AN, Charro, M, Ginard, D, Sadornil, CD, Ochoa, OM, Busquets, D, Iyo, E, Casbas, AG, de la Piscina, PR, Bosca-Watts, MM, Arroyo, M, Garcia, MJ, Hinojosa, E, Gordillo, J, Montiel, PM, Jimenez, BV, Ivorra, CQ, Moron, JMV, Huguet, JM, Gonzalez-Lama, Y, Santos, AIM, Amo, VM, Arranz, MDM, Bermejo, F, Cadilla, JM, de Celix, CR, Salazar, PF, San Roman, AL, Jimenez, N, Garcia-Lopez, S, Figuerola, A, Jimenez, I, Cerezo, FJM, Taxonera, C, Varela, P, de Francisco, R, Monfort, D, Arriero, GM, Hernandez-Camba, A, Alonso, FJG, Van Domselaar, M, Pajares-Villarroya, R, Nunez, A, Moranta, FR, Marin-Jimenez, I, Alonso, VR, Rodriguez, MDM, Camo-Monterde, P, Tercero, IG, Navarro-Llavat, M, Garcia, LA, Cruz, DH, Kloss, S, Passey, A, Novella, C, Vispo, E, Barreiro-de Acosta, M, Gisbert, JP. Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab. Journal of Clinical Medicine. 2022; 11(15)DOI:10.3390/jcm11154518. PMID:35956133. IF:3.900(Q2/4D).
01/07/2022 Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU
Riestra, S, Taxonera, C, Zabana, Y, Carpio, D, Chaparro, M, Barrio, J, Rivero, M, Lopez-Sanroman, A, Esteve, M, de Francisco, R, Bastida, G, Garcia-Lopez, S, Manosa, M, Martin-Arranz, MD, Perez-Calle, JL, Guardiola, J, Munoz, F, Arranz, L, Cabriada, JL, Garcia-Sepulcre, MF, Navarro, M, Montoro-Huguet, MA, Ricart, E, Bermejo, F, Calvet, X, Piqueras, M, Garcia-Planella, E, Marquez, L, Minguez, M, Van Domselar, M, Bujanda, L, Aldeguer, X, Sicilia, B, Iglesias, E, Alcain, G, Perez-Martinez, I, Rolle, V, Castano-Garcia, A, Gisbert, JP, Domenech, E. Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU. Journal of Clinical Medicine. 2022; 11(13)DOI:10.3390/jcm11133915. PMID:35807201. IF:3.900(Q2/4D).
01/12/2024 Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)
Alvarado-Tapias, E, Maya-Miles, D, Albillos, A, Aller, R, Ampuero, J, Andrade, RJ, Arechederra, M, Aspichueta, P, Banales, JM, Blas-Garcia, A, Caparros, E, Delgado, TC, Carrillo-Vico, A, Claria, J, Cubero, FJ, Diaz-Ruiz, A, Fernandez-Barrena, MG, Fernandez-Iglesias, A, Fernandez-Veledo, S, Frances, R, Gallego-Duran, R, Gracia-Sancho, J, Irimia, M, Lens, S, Martinez-Chantar, ML, Minguez, B, Munoz-Hernandez, R, Nogueiras, R, Ramos-Molina, B, Riveiro-Barciela, M, Rodriguez-Peralvarez, ML, Romero-Gomez, M, Sabio, G, Sancho-Bru, P, Ventura-Cots, M, Vidal, S, Gahete, MD. Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH). Gastroenterologia y Hepatologia. 2024; 47(10)DOI:10.1016/j.gastrohep.2024.502207. PMID:38723772. IF:1.900(Q3/7D).
01/12/2024 Perception of the impact of intravenous biological treatment on the work and professional environment in patients with inflammatory bowel disease
González-Muñoza, C, Gely, C, Gordillo, J, Calafat, M, Bertoletti, F, Cañete, F, Mañosa, M, López-Faba, A, Torres, P, Domènech, E, Garcia-Planella, E. Perception of the impact of intravenous biological treatment on the work and professional environment in patients with inflammatory bowel disease. Gastroenterologia y Hepatologia. 2024; 47(10)DOI:10.1016/j.gastrohep.2024.502193. PMID:38723767. IF:1.900(Q3/7D).
01/11/2024 Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU
Casanova, MJ, Caballol, B, García, MJ, Mesonero, F, de Célix, CR, Suárez-Alvarez, P, Ferreiro-Iglesias, R, Martín-Rodríguez, MDM, de Francisco, R, Varela-Trastoy, P, Bastida, G, Carrillo-Palau, M, Núñez-Ortiz, A, Ramírez-de la Piscina, P, Ceballos, D, Hervías-Cruz, D, Muñoz-Pérez, R, Velayos, B, Bermejo, F, Busquets, D, Cabacino, M, Camo-Monterde, P, Marín-Jiménez, I, Muñoz, C, de la Peña-Negro, LC, Sierra-Moros, E, Barrio, J, Brunet-Mas, E, Bujanda, L, Cañete, F, Gomollón, F, Manceñido-Marcos, N, Rodríguez-Lago, I, Rodríguez-Grau, MC, Sicilia, B, Torra-Alsina, S, Arranz-Hernández, L, Carpio, D, García-Sepulcre, MF, González-Muñoza, C, Huguet, JM, Márquez-Mosquera, L, López-Serrano, MP, Ponferrada-Díaz, A, Chaparro, M, Gisbert, JP. Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU. DIGESTIVE AND LIVER DISEASE. 2024; 56(11)DOI:10.1016/j.dld.2024.05.009. PMID:38839456. IF:3.800(Q2/3D).
01/10/2024 Examining the therapeutic landscape of beta-blockers in portal hypertension
Brujats, A, Villanueva, C. Examining the therapeutic landscape of beta-blockers in portal hypertension. Clinical and Molecular Hepatology. 2024; 30(4)DOI:10.3350/cmh.2024.0144. PMID:38447532. IF:16.900(Q1/1D).
01/10/2024 Persistent varices in cured patients: Understanding the role of hepatic venous pressure gradient
Olivas, P, Soler-Perromat, A, Tellez, L, Carrion, JA, Alvarado-Tapias, E, Ferrusquia-Acosta, J, Lens, S, Guerrero, A, Falga, A, Vizcarra, P, Orts, L, Perez-Campuzano, V, Shalaby, S, Torres, S, Baiges, A, Turon, F, Garcia-Pagan, JC, Garcia-Criado, A, Hernandez-Gea, V. Persistent varices in cured patients: Understanding the role of hepatic venous pressure gradient. Jhep Reports. 2024; 6(10)DOI:10.1016/j.jhepr.2024.101170. PMID:39430576. IF:7.500(Q1/2D).
01/10/2024 THE GLOBAL PROFILE OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): CLINICAL PRESENTATION, HISTOLOGIC STAGE, NON-INVASIVE TESTS AND MORTALITY FROM THE GLOBAL NAFLD/MASLD REGISTRY
Younossi, Z, Alkhouri, N, Hagström, H, Kim, SU, Crespo, J, Castera, L, Zheng, MH, Treeprasertsuk, S, Shalimer, D, Alswat, K, Fan, JG, Roberts, S, Tsochatzis, E, Dunn, W, Wong, V, Yilmaz, Y, Francque, S, de Oliveira, C, Pessoa, MG, Ekstedt, M, Goh, GBB, Duseja, A, Chan, WK, Fernandez, MIC, Sebastiani, G, Lampertico, P, Alnaamani, K, Valsan, AK, Holleboom, AG, El-Kassas, M, Choudhary, NS, Vessby, J, Singal, A, Kakizaki, S, Pearlman, B, Gunn, N, Cordie, A, Mauricio, D, Kawaguchi, T, Nadeem, R, Shang, Y, Lee, HW, Iruzubieta, P, Liu, WY, Ananchuensook, P, Yang, RX, Zoncapé, M, Dunn, N, Song, SJ, Gadi, Z, Teh, KKJ, Mahadeva, S, Fabian, LG, Cinque, F, D'Ambrosio, R, Friend, E, Poca, M, Colombu, M, Allen, A, Lazarus, J, Lam, B, de Avila, L, Racila, A, Alqahtani, S, Stepanova, M. THE GLOBAL PROFILE OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): CLINICAL PRESENTATION, HISTOLOGIC STAGE, NON-INVASIVE TESTS AND MORTALITY FROM THE GLOBAL NAFLD/MASLD REGISTRY. HEPATOLOGY. 2024; 80DOI:. PMID:. IF:15.800(Q1/1D).
01/09/2024 An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial
Ortiz, O, Daca-Alvarez, M, Rivero-Sanchez, L, Gimeno-Garcia, AZ, Carrillo-Palau, M, Alvarez, V, Ledo-Rodriguez, A, Ricciardiello, L, Pierantoni, C, Hüneburg, R, Nattermann, J, Bisschops, R, Tejpar, S, Huerta, A, Pons, FR, Alvarez-Urturi, C, López-Vicente, J, Repici, A, Hassan, C, Cid, L, Cavestro, GM, Romero-Mascarell, C, Gordillo, J, Puig, I, Herraiz, M, Betes, M, Herrero, J, Jover, R, Balaguer, F, Pellisé, M. An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial. Lancet Gastroenterology & Hepatology. 2024; 9(9)DOI:10.1016/S2468-1253(24)00187-0. PMID:39033774. IF:38.600(Q1/1D).
01/08/2024 Immune Response and Risk of Decompensation following SARS-CoV-2 Infection in Outpatients with Advanced Chronic Liver Disease
Brujats, A, Huerta, A, Osuna-Gómez, R, Guinart-Cuadra, A, Ferrero-Gregori, A, Pujol, C, Soriano, G, Poca, M, Fajardo, J, Escorsell, A, Gallego, A, Vidal, S, Villanueva, C, Alvarado-Tapias, E. Immune Response and Risk of Decompensation following SARS-CoV-2 Infection in Outpatients with Advanced Chronic Liver Disease. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(15)DOI:10.3390/ijms25158302. PMID:39125872. IF:4.900(Q1/3D).
01/07/2024 Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
Ruiz-Cobo, JC, Llaneras, J, Forns, X, Moya, AG, Amiel, IC, Arencibia, A, Diago, M, Garcia-Samaniego, J, Castellote, J, Llerena, S, Rodriguez-Seguel, E, Mateos, B, Rodriguez, M, Zabal, JMR, Fernandez, I, Calleja, JL, Morillas, RM, Montoliu, S, Andrade, RJ, Aranda, EB, Hernandez-Guerra, M, Mate, CJ, Gonzalez-Santiago, JM, de Cuenca, B, Bernal-Monterde, V, Delgado, M, Turnes, J, Lens, S, Buti, M. Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2024; 60(2)DOI:10.1111/apt.18020. PMID:38695095. IF:6.700(Q1/1D).
28/06/2024 Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry
Ferreiro-Iglesias, R, Silva, SP, Marín, S, Casanova, MJ, Mañosa, M, González-Muñoza, C, de Francisco, R, Caballol, B, Arias, L, Piqueras, M, Zabana, Y, Rivero, M, Calvet, X, Mesonero, F, Trastoy, PV, Nistal, RB, Perosanz, RG, Vega, P, Gonzalez-Vivo, M, Iborra, M, Bermejo, F, Madero, L, Rodríguez-Lago, I, Gonzalez, MR, Vera, I, Díaz, AP, Vela, M, Medina, LT, Van Domselaar, M, Gomollón, F, Iglesias, E, Gisbert, JP, Calafat, M, Giordano, A, Pérez-Martínez, I, Ricart, E, Sicilia, B, Mena, R, Esteve, M, Rivas, C, Brunet-Mas, E, Fernández, C, Turrión, MAD, Jiménez, BV, Calvo, MQ, Expósito, CR, Márquez-Mosquera, L, Nos, P, Granja, A, Gutiérrez, A, Cabriada, JL, Cruz, DH, Calvo, M, Pérez, JP, Díaz, YR, Casal, DB, Menacho, M, Leal, C, Lucendo, AJ, Royo, V, Olivares, S, Herrero, BA, Carrillo-Palau, M, Alvarez, PG, Marcos, NM, Martínez-Pérez, TD, Villafranca, MCM, Almela, P, Argüelles-Arias, F, Legido, J, Coronel, AMF, Nieto, L, Domènech, E, Acosta, MBD. Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2024; 60(5)DOI:10.1111/apt.18133. PMID:38943230. IF:6.700(Q1/1D).
24/06/2024 Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA project
González-Muñoza, C, Calafat, M, Gisbert, JP, Iglesias, E, Minguez, M, Sicilia, B, Aceituno, M, Gomollón, F, Calvet, X, Ricart, E, De Castro, L, Rivero, M, Mesonero, F, Márquez, L, Nos, P, Rodriguez-Pescador, A, Guardiola, J, García-Sepulcre, M, García-López, S, Lorente-Poyatos, RH, Alba, C, Sánchez-Ocaña, R, Vera, I, Madero, L, Riestra, S, Navarro-Llavat, M, Pérez-Calle, JL, Camps, B, Van Domselaar, M, Lucendo, AJ, Martin-Arranz, MD, Montoro-Huguet, MA, Sierra-Ausin, M, Llao, J, Carpio, D, Varela, P, Merino, O, Fernandez-Salazar, L, Piqueras, M, Sese, E, Busquets, D, Tardillo, C, Maroto, N, Riera, J, Martinez-Flores, C, Munoz, F, Gordillo-abalos, J, Bertoletti, F, Garcia-Planella, E, Domènech, E. Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA project. POSTGRADUATE MEDICAL JOURNAL. 2024; DOI:10.1093/postmj/qgae076. PMID:38913019. IF:2.700(Q1/3D).
01/06/2024 Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry
Guerra, I, Barros, F, Chaparro, M, Benítez, JM, Martín-Arranz, MD, de Francisco, R, Piqueras, M, de Castro, L, Carbajo, AY, Bermejo, F, Mínguez, M, Gutiérrez, A, Mesonero, F, Cañete, F, González-Muñoza, C, Calvo, M, Sicilia, B, Alfambra, E, Rivero, M, Lucendo, AJ, Tardillo, CA, Almela, P, Bujanda, L, van Domselaar, M, Ramos, L, Sánchez, MF, Hinojosa, E, Verdejo, C, Gimenez, A, Rodriguez-Lago, I, Manceñido, N, Calle, JLP, Moreno, MD, Delgado-Guillena, PG, Antolin, B, de la Piscina, PR, Casanova, MJ, Escribano, PS, Arranz, EM, Perez-Martínez, I, Mena, R, Morales, NG, Granja, A, Watts, MMB, Francés, R, Fernandez, C, Calafat, M, Roig-Ramos, C, Vera, MI, Carracedo, A, Domènech, E, Gisbert, JP. Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry. DIGESTIVE DISEASES. 2024; 42(3)DOI:10.1159/000537782. PMID:38452742. IF:2.100(Q3/7D).
01/06/2024 The Usefulness of Intraepithelial Lymphocyte Immunophenotype Testing for the Diagnosis of Coeliac Disease in Clinical Practice
Gutiérrez-Rios, L, Calafat, M, Pascual, I, Roig, C, Teniente-Serra, A, Vergés, L, González-Muñoza, C, Vayreda, E, Vázquez, D, Gordillo, J, Mañosa, M, Ramírez, C, Garcia-Planella, E, Planella, M, Domènech, E. The Usefulness of Intraepithelial Lymphocyte Immunophenotype Testing for the Diagnosis of Coeliac Disease in Clinical Practice. Nutrients. 2024; 16(11)DOI:10.3390/nu16111633. PMID:38892566. IF:5.000(Q1/2D).
01/06/2024 Comparison in epidemiologyand outcomes of bacterial infections in patients with cirrhosis between university hospitals with and without liver transplant
Torras, C, Bañares, J, Martí, A, Acin, V, Pagès, L, Gutiérrez, L, Casabella, A, Ferrusquía, JA, Sánchez, J, Pérez, M, Fuertes, D, Garcia, M, Soriano, G, Masnou, H, Amador, A, Cuyas, B, Pericàs, JM, Gasch, O, Solé, C. Comparison in epidemiologyand outcomes of bacterial infections in patients with cirrhosis between university hospitals with and without liver transplant. JOURNAL OF HEPATOLOGY. 2024; 80DOI:. PMID:. IF:33.000(Q1/1D).